The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125704331 12570433 1 I 20150803 20160719 20160719 PER US-BAUSCH-BL-2015-018799 BAUSCH AND LOMB 64.00 YR M Y 170.25000 KG 20160719 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125704331 12570433 1 PS XIFAXAN RIFAXIMIN 1 Oral U 21361 550 MG TABLET BID
125704331 12570433 2 SS LACTULOSE. LACTULOSE 1 U 0
125704331 12570433 3 C METOLAZONE. METOLAZONE 1 Oral 0 5 MG QD
125704331 12570433 4 C SPIRONOLACTONE. SPIRONOLACTONE 1 Oral 0 25 MG QD
125704331 12570433 5 C FUROSEMIDE. FUROSEMIDE 1 Oral 0 80 MG QD
125704331 12570433 6 C CALCITRIOL. CALCITRIOL 1 Oral MONDAY,WEDNESDAY,FRIDAY 0 .5 MG TIW
125704331 12570433 7 C CALCITRIOL. CALCITRIOL 1 Oral TUESDAY, THURSDAY, SATURDAY AND SUNDAY 0 .25 MG
125704331 12570433 8 C POTASSIUM CL POTASSIUM CHLORIDE 1 Oral 0 20 MEQ QD
125704331 12570433 9 C TRAMADOL. TRAMADOL 1 Oral 0 50 MG
125704331 12570433 10 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 0 40 MG QD
125704331 12570433 11 C CARVEDILOL. CARVEDILOL 1 Oral 0 6.25 MG BID
125704331 12570433 12 C ATORVASTATIN ATORVASTATIN 1 Oral 0 10 MG QD
125704331 12570433 13 C LANTUS INSULIN GLARGINE 1 55 UNITS AM, 95 UNITS PM 0
125704331 12570433 14 C VITAMIN B12 CYANOCOBALAMIN 1 0
125704331 12570433 15 C APIDRA INSULIN GLULISINE 1 SLIDING SCALE 0
125704331 12570433 16 C VITAMIN D CHOLECALCIFEROL 1 Oral 50000 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125704331 12570433 1 Ammonia increased
125704331 12570433 2 Ammonia increased
125704331 12570433 3 Diuretic therapy
125704331 12570433 4 Diuretic therapy
125704331 12570433 5 Mineral supplementation
125704331 12570433 6 Mineral supplementation
125704331 12570433 8 Mineral supplementation
125704331 12570433 9 Pain
125704331 12570433 10 Gastrooesophageal reflux disease
125704331 12570433 11 Cardiac disorder
125704331 12570433 12 Blood cholesterol increased
125704331 12570433 13 Diabetes mellitus
125704331 12570433 14 Anaemia
125704331 12570433 15 Diabetes mellitus
125704331 12570433 16 Mineral supplementation

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125704331 12570433 Ammonia increased
125704331 12570433 Amnesia
125704331 12570433 Blood glucose increased
125704331 12570433 Disorientation
125704331 12570433 Drug dose omission

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125704331 12570433 1 2014 20150731 0
125704331 12570433 3 2014 0
125704331 12570433 4 2014 0
125704331 12570433 5 2014 0
125704331 12570433 9 201507 0
125704331 12570433 10 2000 0
125704331 12570433 11 2014 0
125704331 12570433 12 201504 0
125704331 12570433 13 2014 0
125704331 12570433 14 2014 0
125704331 12570433 15 2014 0
125704331 12570433 16 2014 0